Dr. Caitlin Stamatis is a clinical psychologist and researcher specializing in digital mental health, behavioral health technology, and AI-enabled care. As Head of Clinical Research at Slingshot AI, she leads research on the safety, efficacy, and responsible development of Ash and other purpose-built AI systems for mental health.

Over the past decade, Dr. Stamatis has held research and leadership roles across healthcare and technology, including at Google, Otsuka Pharmaceutical, and Akili Interactive. At Akili, she helped develop and validate novel digital measures of cognitive functioning derived from passively collected behavioral data, contributing to peer-reviewed research and the commercialization of Akili's Focus Score cognitive biomarker. Her work has supported the development and evaluation of pioneering digital therapeutics for conditions including ADHD and major depressive disorder.

Dr. Stamatis has authored research spanning digital phenotyping, passive sensing, machine learning, depression risk prediction, and technology-enabled mental healthcare. Her publications have examined topics including smartphone-based mental health monitoring, algorithmic bias in AI systems, and digital biomarkers for depression and anxiety.

She has served as adjunct faculty at Northwestern University Feinberg School of Medicine and holds leadership positions within organizations advancing the field of digital medicine, including the Society for Digital Mental Health.

Dr. Stamatis earned her B.A. in Psychology from Columbia University, where she was awarded a Fulbright Fellowship. She received her Ph.D. in Clinical Psychology with a quantitative specialization and completed her clinical residency at Weill Cornell Medicine.